发明授权
EP1761529B3 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
有权
PYRROLOPYRIDINDERIVATE及其作为CRTH2拮抗剂
- 专利标题： PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
- 专利标题（中）： PYRROLOPYRIDINDERIVATE及其作为CRTH2拮抗剂
-
申请号： EP05751627.0申请日： 2005-06-16
-
公开(公告)号： EP1761529B3公开(公告)日： 2011-06-15
- 发明人: BALA, Kamlesh, Novartis Horsham Research Centre , LEBLANC, Catherine, Novartis Horsham Research Ctr. , SANDHAM, David Andrew, Novartis Horsham Res. Ctr. , TURNER, Katharine L., Novartis Horsham Res. Ctr. , WATSON, Simon James, Novartis Horsham Res. Ctr. , BROWN, Lyndon Nigel , COX, Brian, Novartis Horsham Res. Ctr
- 申请人： Novartis AG
- 申请人地址： Lichtstrasse 35 4056 Basel CH
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： Lichtstrasse 35 4056 Basel CH
- 代理机构： Larbig, Karen Dorothee
- 优先权： GB0413619 20040617; GB0507693 20050415
- 国际公布： WO2005123731 20051229
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437
摘要：
There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
公开/授权文献
信息查询
